Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure

Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure

Abstract Background Whereas selective sodium-glucose cotransporter 2 (SGLT2) inhibitors consistently showed cardiovascular protective effects in large outcome trials independent of the presence of type 2 diabetes mellitus (T2DM), the cardiovascular effects of dual SGLT1/2 inhibitors remain to be elu...

Full description

Bibliographic Details
Main Authors: Alex Ali Sayour, Attila Oláh, Mihály Ruppert, Bálint András Barta, Eszter Mária Horváth, Kálmán Benke, Miklós Pólos, István Hartyánszky, Béla Merkely, Tamás Radovits
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Cardiovascular Diabetology
Subjects:
Sodium-glucose cotransporter 1
SGLT2 inhibitor
Dual SGLT1/2 inhibitors
Heart failure
Cardiac resynchronization therapy
Online Access:http://link.springer.com/article/10.1186/s12933-020-01141-1

Internet

http://link.springer.com/article/10.1186/s12933-020-01141-1

Similar Items